Thursday, April 17, 2008

Serum dopamine-beta-hydroxylase and depression

Friedhelm Lamprecht1, Michael H. Ebert1, Ibrahim Turek1, 2 and Irwin J. Kopin1

(1) Laboratory of Clinical Science, NIMH, 20014 Bethesda, Maryland
(2) Maryland Psychiatric Research Center, Catonsville, Maryland

Received: 18 June 1974

Abstract Serum dopamine-beta-hydroxylase (DBH) activity was studied in unipolar and bipolar depressed patients who were free of medication and in normal controls. No significant difference was found. A second group of depressed patients were studied during a course of electroconvulsive shock treatment (ECT). A small, but significant, increase in DBH activity was found 5 min after a single modified convulsion, suggesting release of DBH into the circulation. Also a small, but significant, increase in the baseline level of DBH activity was found at the ninth treatment compared to the first treatment. A single electroconvulsive shock administered to rats produced a significant elevation of both plasma epinephrine and norepinephrine at 1 and 5 min post convulsion and a significant, but smaller, elevation of plasma DBH at 5 min post convulsion in adrenalectomized rats.

Key words Electroconvulsive Shock Treatment - Serum Dopamine-Beta-Hydroxylase - Depression - Catecholamines - Sympathetic Nervous System

JournalPsychopharmacology
PublisherSpringer Berlin / Heidelberg
ISSN0033-3158 (Print) 1432-2072 (Online)
IssueVolume 40, Number 3 / September, 1974